Fundz
Back to SEC Filings
10-QHIGH RiskDETERIORATING

PAVmed Inc.

Filed: May 14, 2026 CIK: 0001624326
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

PAVmed shows severe operational deterioration with minimal revenue ($22K) against massive operating losses ($8M), heavy reliance on convertible debt financing, and substantial equity dilution. The company appears to be burning cash rapidly while generating virtually no meaningful revenue from operations.

Red Flags Detected (7)

Virtually no operating revenue ($22K quarterly) relative to $8M operating loss

Operating loss increased 47% year-over-year ($8.0M vs $5.4M)

Cash position remains critically low at $6.4M with high burn rate

4 more red flags detected

Key Takeaways

Company operates as a development-stage entity with no meaningful commercial revenue

Financial sustainability depends entirely on external financing and fair value gains

2 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateMay 14, 2026
Risk LevelHIGH
TrendDETERIORATING
AI Confidence85%
Red Flags7

What This Means

High Risk Filing: This company is showing signs of financial stress or significant operational challenges.

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings